What You Should Know:
- Hims & Hers Health, Inc., the leading health and wellness platform, and Connecticut’s most transformative health system, Hartford HealthCare (HHC), today announced a strategic partnership that broadens access to in-person healthcare services.
- The collaboration provides patients with an enhanced and connected healthcare experience when they need care outside the Hims & Hers platform. Licensed medical providers on the platform will be able to seamlessly refer patients to HHC’s distinguished primary and specialty care provider network, when necessary. This can include when Hims & Hers customers have more complex health histories or medical needs, those that may require additional in-person follow-up care or evaluations or are in need of care for conditions not currently supported by the Hims & Hers platform
Enhancing Specialized Care: A Focus on Cardiovascular Health with HHC
Hims & Hers reinforces its commitment to accessible, high-quality care by integrating the esteemed Connecticut-based healthcare system, HHC, into its growing provider network. With this addition, the company’s medical system partner network now spans 11 states and Washington, D.C.
As Hims & Hers expands into personalized treatments, such as Heart Health by Hims and Weight Loss by Hims & Hers, the inclusion of HHC further strengthens the company’s emphasis on quality care. HHC’s renowned Heart & Vascular Institute, a national leader in cardiovascular disease care, offers personalized treatments and advanced cardiac procedures, making it a significant addition to the expanding network.
“We partnered with Hartford HealthCare because of its unwavering commitment to delivering exceptional care, embracing innovation, and fostering a culture of compassion,” said Hims & Hers Chief Medical Officer Patrick Carroll, MD. “With a focus on patient well-being, cutting-edge treatments, and a dedicated team of healthcare professionals, we know our customers in Connecticut will always receive the best care when they need to see a specialist for treatment beyond our platform.”
